Treatment of Venous Thromboembolism in Real-Life Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Effect of Mepolizumab in Severe Bilateral Nasal Polyps
- Status
- COMPLETED
- Phase
- PHASE3
APRIL (AbatacePt in Rheumatoid Arthritis-ILD)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting
- Status
- COMPLETED
- Phase
- PHASE1
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
- Status
- COMPLETED
- Phase
- PHASE1
BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy
- Status
- COMPLETED
- Phase
- N/A
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Orencia in Patients With Myasthenia Gravis
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
- Status
- COMPLETED
- Phase
- N/A
Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin
- Status
- COMPLETED
- Phase
- PHASE1